Lexicon Pharmaceuticals, Inc. (LXRX) Description, Stock price, News & Info

#ThinkSabio Latest News

LXRX – Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific SessionsPresentations highlight consistent A1c reductions with sotagliflozin in type 1 diabetes and pharmacokinetics of pilavapadin across renal function groups